Katherine Callaway Kim

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

Hot off the @JAMA_current press: a study comparing drug shortages in the 🇺🇸&🇨🇦, by team including CP3's @CallawayKim4 @walidgellad & @Sudamonas. (w/ CP3 alum @ihdezdelso & CP3 friend @Mina__T).

They found drug-related supply chain issue reports were 40% less likely to result in meaningful drug shortages in 🇨🇦 compared with 🇺🇸.

https://t.co/LWn00dOXLx

1/2

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

Join us in congratulating the new Dr Katherine Callaway Kim (@CallawayKim4)! Dr Callaway Kim defended her dissertation, the impact of drug shortages on US patients with hypertension, this morning. We’re beaming with pride!

@PittPubHealth @PittHPM @Sudamonas

[Katherine Callaway Kim @CallawayKim4]

#NewProfilePic

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

CP3's @Sudamonas & @CallawayKim4 are doing major work to understand the causes of drug shortages and how to prevent them from happening in the future.

https://t.co/cKK6H4NwXB

[Katherine Callaway Kim @CallawayKim4]

New #drugshortages paper out yesterday in @JAMANetworkOpen with @Sudamonas @Mina__T @ihdezdelso @walidgellad!

[SUDAmonas @Sudamonas]

NEW 🔥 paper in JAMA Network Open by @CallawayKim4 @Mina_T @ihdezdelso @SUDAmonas funded by an @AHRQNews R01. We are the first to show that reported supply chain events actually impact national #drugsupply. @US_FDA, @IQVIA_Institute, @ASHPOfficial

[JAMA Network Open @JAMANetworkOpen]

One in 7 supply chain issue reports to @US_FDA or ASHP were associated with drug shortages from 2017-2021. Supply disruptions increased across-the-board early in the #COVID19 pandemic. https://t.co/bj0UyT2ePb @CallawayKim4 @Sudamonas

[Erin Fox @foxerinr]

Biden is aiming to tackle rampant drug shortages with a new multibillion-dollar plan for Congress to pressure hospitals into paying more for generic medicines. https://t.co/Y0i7wfo7Tj via @business

https://t.co/U6SlUZ1QOo

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

❓Did the #valsartan recall affect ❤️failure patients' care?
✅Analysis shows no effect on short-term outcomes.

More: https://t.co/OKGNyukiOW

From CP3's @CallawayKim4 @walidgellad @Sudamonas

@IntPharmacoEpi @Mina__T @ihdezdelso

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

🚨Students!🚨
If you're interested in #Pharmacoequity and want to attend our #Pharmacoequity2024 Conference in Pittsburgh to learn from & network with national experts, we have a SCHOLARSHIP OPPORTUNITY coming soon! Watch this space!

https://t.co/oCLMQoKaep

[Pitt General Internal Medicine @PittGIM]

Join us on Zoom next Thursday when @CallawayKim4 joins us to discuss #DrugShortages in the US and Canada!

Register for this #PittHSRseminar here: https://t.co/ae2glK9nC2

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

More evidence that #drugshortages disrupt care: Pts w/hypertension & active valsartan supply had ⬆️in cardiac events w/in 6 mos of drug recall.

CP3 co-authors @Sudamonas @CallawayKim4 @walidgellad

@JAHA_AHA
https://t.co/665RKSxKrE

[Kristina Jenei @kjmeetswrld]

🚨New essay out today in @TheLancetOncol w/ @DrMarkLythgoe @KNVokinger

We outline the cancer medicine shortage in the US, reasons 🇺🇸 was so much worse than Europe, and ponder solutions that might help in the long run.

A thread/1

https://t.co/2ML0NvW26A

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

@GovCanHealth developed the Tiered Notification & Communication Framework to address #drugshortages. This analysis looks at purchasing trends after Tier 3 shortages.

Read in @PLOSONE:
https://t.co/JgOtAQmeWC

With CP3's @CallawayKim4 @Sudamonas

[Katherine Callaway Kim @CallawayKim4]

What a great week of learning at #ICPE2023! An evening walk on the Halifax boardwalk made for a perfect ending to an awesome conference. Looking forward to Berlin in 2024!

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

This afternoon at #ICPE23, head over to MR201 for a presentation from CP3 Associate Director @Sudamonas!

@PittGIM @PittHealthSci @PittDeptofMed

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

Attending #ICPE23? Don't miss these presentations from CP3's @Sudamonas & @CallawayKim4!

🌟Congrats to @CallawayKim4 for having the most highly rated student abstract in the Drug Utilization Research category! Award ceremony Saturday!

@PittGIM @PittHPM

[Katherine Callaway Kim @CallawayKim4]

Despite an unexpected night in Toronto due to flight delays, very happy to be in Halifax enjoying my first in-person #pharmepi conference at #ICPE23. Awesome presentations followed by Canadian maple walnut ice cream with friends made for an awesome first day!

[Dr. Robert M. Califf @DrCaliff_FDA]

The U.S. Food and Drug Administration is working closely with Pfizer to assess the impact of the damage at Pfizer’s Rocky Mount, North Carolina, facility.
https://t.co/Q4d5fkdZFB

[Pitt General Internal Medicine @PittGIM]

🔊 The CRHC Data Center is hiring a #DataAnalyst! Candidates must possess expert knowledge of #ResearchMethodology & #statistics to manage & analyze complex #ResearchStudyData. MS preferred, BS required.

💻 Learn more and apply: https://t.co/fMn9mAVvM5

[Katherine Callaway Kim @CallawayKim4]

Had an awesome time visiting Boston friends and family and learning about advanced confounding adjustment in #causalinference this past week! Thank you for the opportunity to participate in CAUSALab 2023!